Cumberland Pharmaceuticals (CPIX) Treasury Shares (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Treasury Shares of $7170.0 for Q2 2025, down 97.06% sequentially from $243705.0 in Q1 2025, and down 94.34% YoY from $126689.0 in Q2 2024.
Cumberland Pharmaceuticals (CPIX) Treasury Shares (2011 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Treasury Shares for 9 years, with the latest figure at $7170.0 in Q2 2025.
- Quarterly Treasury Shares fell 94.34% year-over-year to $7170.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $7170.0 (down 94.34% YoY) and the FY2019 annual result came in at $3.5 million, up 21.16% from the prior year.
- Treasury Shares slipped to $7170.0 in Q2 2025 per CPIX's latest filing, from $243705.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $568181.0 in Q4 2021 and troughed at $112585.0 in Q4 2025.
- A 5-year average of $295381.6 and a median of $260566.0 in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares surged 155.4% in 2023, then tumbled 94.34% in 2025.
- Over 5 years, Treasury Shares stood at $1.0 million in 2021, then plunged by 92.12% to $78793.0 in 2022, then soared by 155.4% to $201237.0 in 2023, then surged by 148.46% to $500000.0 in 2024, then plunged by 98.57% to $7170.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $7170.0, $243705.0, and $500000.0 for Q2 2025, Q1 2025, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61,001.00 |
| Mar 31, 2026 | 61,001.00 |
| Dec 31, 2025 | 112,585.00 |
| Dec 31, 2025 | 112,585.00 |
| Jun 30, 2025 | 7,170.00 |
| Jun 30, 2025 | 7,170.00 |
| Mar 31, 2025 | 243,705.00 |
| Mar 31, 2025 | 243,705.00 |
| Dec 31, 2024 | 139,825.00 |
| Dec 31, 2024 | 139,825.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 126,689.00 |
| Jun 30, 2024 | 126,689.00 |
| Mar 31, 2024 | 246,599.00 |
| Mar 31, 2024 | 246,599.00 |
| Dec 31, 2023 | 260,566.00 |
| Dec 31, 2023 | 260,566.00 |
| Sep 30, 2023 | 201,237.00 |
| Sep 30, 2023 | 201,237.00 |